Hyperion DeFi, Inc. (HYPD)
2.34
-0.04
(-1.47%)
USD |
NASDAQ |
Nov 19, 16:00
2.35
+0.01
(+0.43%)
After-Hours: 20:00
Hyperion DeFi Total Liabilities (Quarterly) : 4.199M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.199M |
| June 30, 2026 | 11.20M |
| March 31, 2026 | 11.57M |
| December 31, 2025 | 10.70M |
| September 30, 2025 | 12.03M |
| June 30, 2025 | 18.30M |
| March 31, 2025 | 15.70M |
| December 31, 2024 | 16.76M |
| September 30, 2024 | 19.08M |
| June 30, 2024 | 21.36M |
| March 31, 2024 | 24.36M |
| December 31, 2023 | 19.78M |
| September 30, 2023 | 19.09M |
| June 30, 2023 | 18.82M |
| March 31, 2023 | 13.50M |
| December 31, 2022 | 13.80M |
| September 30, 2022 | 11.08M |
| June 30, 2022 | 12.00M |
| March 31, 2022 | 10.39M |
| December 31, 2021 | 11.19M |
| Date | Value |
|---|---|
| September 30, 2021 | 20.75M |
| June 30, 2021 | 21.59M |
| March 31, 2021 | 16.71M |
| December 31, 2020 | 18.60M |
| September 30, 2020 | 7.197M |
| June 30, 2020 | 3.108M |
| March 31, 2020 | 2.583M |
| December 31, 2019 | 2.957M |
| September 30, 2019 | 2.478M |
| June 30, 2019 | 2.418M |
| March 31, 2019 | 2.568M |
| December 31, 2018 | 3.140M |
| September 30, 2018 | 1.732M |
| June 30, 2018 | 1.280M |
| March 31, 2018 | 1.123M |
| December 31, 2017 | 0.5526M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.4237M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint, Inc. | 57.63M |
| ANI Pharmaceuticals, Inc. | 930.55M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 115.90B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 146.29M |
| Shareholders Equity (Quarterly) | 142.09M |
| Debt to Equity Ratio | 0.005 |
| Current Ratio | 3.756 |
| Net Debt Paydown Yield | 2.68% |